Previous Close | 0.1040 |
Open | 0.1080 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.0880 - 0.1080 |
52 Week Range | 0.0034 - 0.6890 |
Volume | |
Avg. Volume | 31,845 |
Market Cap | 19.722M |
Beta (5Y Monthly) | 0.03 |
PE Ratio (TTM) | 18.19 |
EPS (TTM) | 0.0050 |
Earnings Date | Nov 15, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for CHUC
Charlie's best-selling e-liquids remain in the select minority of 2020 PMTA submissions to the FDA - across the entire vapor products industry - that are still viableCOSTA MESA, CA / ACCESSWIRE / May 16, 2022 / Charlie's Holdings, Inc. (OTCQB:CHUC) ("Charlie's" or the "Company"), an industry leader in the premium, nicotine-based, vapor products space, today reported results for the first quarter ended March 31, 2022, and provided an update on recent business highlights.
Charlie's best-selling e-liquids remain in the select minority of PMTA submissions to the FDA - across the entire vapor products industry - that are still viableCOSTA MESA, CA / ACCESSWIRE / April 12, 2022 / Charlie's Holdings, Inc. (OTCQB:CHUC) ("Charlie's" or the "Company"), an industry leader in the premium, nicotine-based, e-cigarette space, today reported results for the fourth quarter and full year ended December 31, 2021, and provided an update on recent business highlights.
Carmines has submitted hundreds of PMTAs to the FDA and spearheaded the successful MRTPA submitted by 22nd Century Group (NASDAQ: XXII) that won an FDA marketing order in December 2021.COSTA MESA, CA / ACCESSWIRE / March 2, 2022 / Charlie's Holdings, Inc.